- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06272929
Serum Elafin and Vascular Affection in Behcet Disease
Serum Elafin: A Biomarker in Behcet Disease and Its Relation to Vascular Involvement and Disease Activity
To measure the level of serum elafin in patients with BD. To assess the relation between serum elafin levels and disease activity. To evaluate the vascular complications in BD and determine their relationship with disease activity.
To assess the correlation between serum elafin and vascular affection and their relation with disease activity.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Lobna Amer, MD
- Phone Number: 01019313530
- Email: lobnaamer20@gmail.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
Patients diagnosed as BD. Age of all participants (20-45) years.
Exclusion Criteria:
Age <20 or >45 years. Other autoimmune diseases. Cardiovascular diseases (heart failure, myocardial ischemia). Possible related risk factors (e.g. diabetes, dyslipidemia, smoking). chronic conditions (e.g. chronic kidney disease, malignancy, autoimmune diseases).
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
45 patients with behcet disease
|
doppler US
|
45 healthy participants
|
doppler US
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Measuring the level of serum Elafin in patients with BD in comparison to healthy participants.
Time Frame: within one year
|
Measuring the level of serum Elafin in patients with BD in comparison to healthy participants.
|
within one year
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Calamia KT, Schirmer M, Melikoglu M. Major vessel involvement in Behcet's disease: an update. Curr Opin Rheumatol. 2011 Jan;23(1):24-31. doi: 10.1097/BOR.0b013e3283410088.
- Kutlay A, Kose AA. Serum Elafin as a Potential Marker of Disease Activity in Behcet's Disease. Indian J Dermatol. 2023 Jul-Aug;68(4):372-376. doi: 10.4103/ijd.ijd_913_22.
- Yazici Y, Hatemi G, Bodaghi B, Cheon JH, Suzuki N, Ambrose N, Yazici H. Behcet syndrome. Nat Rev Dis Primers. 2021 Sep 16;7(1):67. doi: 10.1038/s41572-021-00301-1.
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- behcet and vascular
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Behcet Disease and Vascular Affection
-
Assiut UniversityNot yet recruitingBehcet Disease and Vascular Involvement
-
Novartis PharmaceuticalsCompleted
-
Janssen Korea, Ltd., KoreaCompleted
-
Yonsei UniversityRecruitingIntestinal Behcet DiseaseKorea, Republic of
-
Silk Road Therapies, Inc.Not yet recruitingBehcet Syndrome | Behcet DiseaseUnited States
-
Nobel PharmaceuticalsAinos, Inc. (f/k/a Amarillo Biosciences Inc.CompletedBehcet Syndrome | Behcet Disease | Mucocutaneous UlcerationTurkey
-
Novartis PharmaceuticalsCompletedBehcet DiseaseIndia, Turkey, Spain, Germany, Italy, France, Israel, Greece, Korea, Republic of, Hong Kong, United States, Egypt, Jordan, Singapore, Switzerland, Taiwan, Tunisia
-
Peking Union Medical College HospitalNot yet recruitingAneurysm | Behcet Syndrome, Vascular TypeChina
-
Istanbul UniversityUnknownFMF | Behcet DiseaseTurkey
Clinical Trials on doppler ultrasound
-
The University of Texas Health Science Center,...University of Alabama at BirminghamCompleted
-
Ramsay Générale de Santémermoz hospitalRecruitingUpper Aero-intestinal Tract Cancer | Supraclavicular Flap | Anterior Thoracic Perforator ArteryFrance
-
Southeast University, ChinaQinghai UniversityRecruiting
-
Assiut UniversityNot yet recruitingUrinary Tract Injuries During Caesarean Section for Morbidly Adherent Placenta: Prospective and Retrospective StudyEgypt
-
Assiut UniversityUnknown
-
Central Hospital, Nancy, FranceUnknownCritically Ill | Central Venous Catheter Thrombosis | PARENTERAL NUTRITION | POST OPERATIVEFrance
-
Echosense Ltd.TerminatedSystemic Sclerosis | Pulmonary HypertensionIsrael
-
Echosense Ltd.TerminatedSystemic Sclerosis | Pulmonary HypertensionIsrael
-
Rambam Health Care CampusUnknownThrombosis of Portal Venous System.Israel
-
Centre Hospitalier le MansRecruitingSeptic ThrombophlebitisFrance